• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Influence of centrosome amplification on chromosome instability and prognosis in bladder cancer

Research Project

Project/Area Number 15390492
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionYamaguchi University

Principal Investigator

MATSUYAMA Hideyaru  Yamaguchi University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (70209667)

Co-Investigator(Kenkyū-buntansha) NAITO Katsusuke  Yamaguchi University, Faculty of Medicine, Professor, 医学部, 教授 (60115251)
SASAKI Kohsuke  Yamaguchi University, Faculty of Medicine, Professor, 医学部, 教授 (80116722)
OKUDA Masaru  Yamaguchi University, Veterinary, Associate Professor, 医学部, 助教授 (10325243)
吉弘 悟  山口大学, 医学部附属病院, 講師 (40284260)
Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥12,400,000 (Direct Cost: ¥12,400,000)
Fiscal Year 2005: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2004: ¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 2003: ¥8,400,000 (Direct Cost: ¥8,400,000)
Keywordscentrosome amplification / bladder cancer / Aurora-A / FISH / tumor recurrence / tumor progression / chromosomal instability / 20q13 gain / 中身体複製異常 / Aurola A / CGH
Research Abstract

Clinical investigations :
Totally, 100 cases of clinical bladder cancer were studied on the relationship among centrosome amplification (CA), chromosome 20q13 gain, Aurora-A overexpression, chromosomal instability (CIN), aberrant expression of p53 protein, microsatellite instability (MSI), Polo-like kinase, a cell cycle-related kinase protein, (PLK-1), and patient prognosis. MSI was found only in 9 cases (9%) who showed good prognosis without CA, 20q13 gain, tumor progression. The frequency of MSI in bladder cancer was much lower than that of colo-rectal cancer reported. In contrast, CA was detected in 49 cases (49%) who showed poor prognosis with CA, 20q13 gain, Aurora-A overexpression, aberrant expression of p53 protein, and tumor progression. Overexpression of PLK-1 was significant correlation with CA, and found more in cases with higher grade, multiple tumor number, positive urine cytology. Based on these results, two hypotheses were postulated, #1 bladder cancer was biologically classified into two categories by genomic instability, i.e. CIN with poor prognosis, and MSI with good prognosis in terms of tumor progression, #2 overexpression of PLK-1 was involved in the mechanism of occurrence of CA, thereby induce the tumor progression.
Basic investigations :
In order to clarify the mechanism of the occurrence of CA and to seek the relevant gene (s) for CA, high-throughput gene expression profile was carried out by microarray technique on several mouse embryonic cell lines, biologically possessing p53 knockout and CA in character. As a result, down-regulation of BubR1, a pivotal kinase protein concerning mitotic checkpoint, was linked to the occurrence of CA, while CA was eliminated by BubR1 tranfection. From these results, it was suggested that CA may arise from the cooperation between functional loss of p53, leading to the loss of post-mitotic checkpoint at G1 phase, and down-regulation of BnbR1 expression, leading to the escape from mitotic checkpoint at M phase.

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • Research Products

    (16 results)

All 2006 2005 2004

All Journal Article (14 results) Patent(Industrial Property Rights) (2 results)

  • [Journal Article] Biological characteristics in bladder cancer depend on the types of genetic instability2006

    • Author(s)
      Yamamoto, Y.
    • Journal Title

      Clinical Cancer Research 12

      Pages: 2752-2758

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.2006

    • Author(s)
      Yamamoto, Y.
    • Journal Title

      Oncology (In press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Biological characteristics in bladder cancer depend on the types of genetic instability2006

    • Author(s)
      Yamamoto, Y.et al.
    • Journal Title

      Clinical Cancer Research 12

      Pages: 2752-2758

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.2006

    • Author(s)
      Yamamoto, Y.et al.
    • Journal Title

      Oncology (in press)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Biological characteristics in bladder cancer depend on the type of genetic instability2006

    • Author(s)
      Yoshiaki Yamamoto et al.
    • Journal Title

      Clin.Cancer Res. (In press)

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Detection of centrosome amplifications as a surrogate marker of dysfunction in the p53 pathway2005

    • Author(s)
      Kaneko, N.
    • Journal Title

      Veterinary and Comparative Oncology 3

      Pages: 203-210

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR12005

    • Author(s)
      Oikawa, T.
    • Journal Title

      Molecular and Cellular Biology 25

      Pages: 4046-4061

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Detection of centrosome amplifications as a surrogate marker of dysfunction in the p53 pathway2005

    • Author(s)
      Kaneko, N.et al.
    • Journal Title

      Veterinary and Comparative Oncology 3

      Pages: 203-210

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Transcriptional control of BubR1 by p53 suppression of centrosome amplification by BubR12005

    • Author(s)
      Oikawa, T.et al.
    • Journal Title

      Molecular and Cellular Biology 25

      Pages: 4046-4061

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Centrosome Hyperamplification predicts progression and tumor recurrence in bladder cancer2004

    • Author(s)
      Yamamoto, Y.
    • Journal Title

      Clinical Cancer Research 10

      Pages: 6449-6455

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Centrosome hyper-amplification predicts progression and tumor recurrence in bladder cancer2004

    • Author(s)
      Yamamoto, Y.et al.
    • Journal Title

      Clinical Cancer Research 10

      Pages: 6449-6455

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Journal Article] Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer2004

    • Author(s)
      Yoshiaki Yamamoto et al.
    • Journal Title

      Clinical Cancer Research 10

      Pages: 6449-6455

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Bladder cancer with centrosome amplification can be classified into two subtype by 20q12 gain2004

    • Author(s)
      Yoshiaki Yamamoto et al.
    • Journal Title

      The Journal of Urology 173(Suppl)

      Pages: 167-167

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer2004

    • Author(s)
      Hideyasu Matsuyama et al.
    • Journal Title

      The Journal of Urology 173(Suppl)

      Pages: 168-168

    • Related Report
      2004 Annual Research Report
  • [Patent(Industrial Property Rights)] 中心体複製異常を指標とした膀胱癌の予防診断2005

    • Inventor(s)
      松山豪泰
    • Industrial Property Rights Holder
      加藤 紘
    • Industrial Property Number
      2005-010012
    • Filing Date
      2005-03-31
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 中心体複製異常を指標とした膀胱癌の予後診断2005

    • Inventor(s)
      松山豪泰
    • Industrial Property Rights Holder
      山口大学
    • Industrial Property Number
      2005-100120
    • Filing Date
      2005-03-31
    • Related Report
      2004 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi